{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:26:23Z","timestamp":1784204783725,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-000875"],"award-info":[{"award-number":["INV-000875"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2023.11.045","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T06:41:15Z","timestamp":1701326475000},"page":"1445-1453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops"],"prefix":"10.1016","volume":"42","author":[{"given":"Shahida","family":"Baqar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Bonavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Louis Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Hanevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Hasso-Agopsowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hausdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calman A.","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Mantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Omore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pavlinac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Phalipon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Poly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheshi N.","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Rogawski McQuade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo B.","family":"Sztein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.11.045_b0005","unstructured":"WHO Immunization dashboard. World Health Organization (WHO). Published 2022. Accessed December 15, 2022. https:\/\/immunizationdata.who.int\/."},{"key":"10.1016\/j.vaccine.2023.11.045_b0010","unstructured":"Pakistan becomes first country to introduce new typhoid vaccine into routine immunisation program. Gavi. Published November 15, 2019. Accessed February 15, 2022. https:\/\/www.gavi.org\/news\/media-room\/pakistan-becomes-first-country-introduce-new-typhoid-vaccine-routine-immunisation?gclid=EAIaIQobChMIjNKTv7Cp_QIVB2-GCh26CgThEAAYASAAEgLCfPD_BwE."},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.045_b0015","doi-asserted-by":"crossref","first-page":"e1402","DOI":"10.1016\/S2214-109X(21)00316-8","article-title":"Association of enteropathogen detection with diarrhoea by age and high versus low child mortality settings: a systematic review and meta-analysis","volume":"9","author":"Baker","year":"2021","journal-title":"Lancet Global Health"},{"issue":"52","key":"10.1016\/j.vaccine.2023.11.045_b0020","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1016\/j.vaccine.2021.11.033","article-title":"World Health Organization Expert Working Group: recommendations for assessing morbidity associated with enteric pathogens","volume":"39","author":"Hasso-Agopsowicz","year":"2021","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.045_b0025","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/ije\/dyac098","article-title":"Case fatality risk of diarrhoeal pathogens: a systematic review and meta-analysis","volume":"51","author":"Asare","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"32","key":"10.1016\/j.vaccine.2023.11.045_b0030","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1016\/j.vaccine.2021.05.086","article-title":"Global diarrhoea-associated mortality estimates and models in children: recommendations for dataset and study selection","volume":"39","author":"Butkeviciute","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.045_b0035","doi-asserted-by":"crossref","first-page":"e1011","DOI":"10.1093\/cid\/ciab062","article-title":"Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework","volume":"73","author":"Vekemans","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.045_b0040","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2666-5247(22)00303-2","article-title":"The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline","volume":"4","author":"Frost","year":"2023","journal-title":"Lancet Microbe"},{"issue":"7806","key":"10.1016\/j.vaccine.2023.11.045_b0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-2238-4","article-title":"Childhood vaccines and antibiotic use in low- and middle-income countries","volume":"581","author":"Lewnard","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.045_b0050","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study","volume":"9","author":"Yousafzai","year":"2021","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2023.11.045_b0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-011341","article-title":"Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study","volume":"8","author":"Kim","year":"2023","journal-title":"BMJ Global Health"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.045_b0060","doi-asserted-by":"crossref","first-page":"e880","DOI":"10.1016\/S2214-109X(23)00192-4","article-title":"Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study","volume":"11","author":"Anderson","year":"2023","journal-title":"Lancet Global Health"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.045_b0065","doi-asserted-by":"crossref","first-page":"e892","DOI":"10.1016\/S2214-109X(23)00050-5","article-title":"Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study","volume":"11","author":"Puett","year":"2023","journal-title":"Lancet Global Health"},{"issue":"16","key":"10.1016\/j.vaccine.2023.11.045_b0070","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.vaccine.2023.03.003","article-title":"Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: report of an expert convening","volume":"41","author":"Riddle","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.045_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100368","article-title":"Exploring Shigella vaccine priorities and preferences: results from a mixed-methods study in low- and middle-income settings","volume":"15","author":"Fleming","year":"2023","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2023.11.045_b0080","first-page":"11","article-title":"Multipathogen analysis of IgA and IgG antigen specificity for selected pathogens in milk produced by women from diverse geographical regions: the INSPIRE Study","author":"McGuire","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.11.045_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-022-02360-w","article-title":"Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection","volume":"93","author":"Bode","year":"2023","journal-title":"Pediatr Res"},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.045_b0090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158030","article-title":"Strong off-target antibody reactivity to malarial antigens induced by RTS, S\/AS01E vaccination is associated with protection","volume":"7","author":"Maci\u00e0","year":"2022","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.vaccine.2023.11.045_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111216","article-title":"Systems approach to define humoral correlates of immunity to Shigella","volume":"40","author":"Bernshtein","year":"2022","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.045_b0100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(21)00615-0","article-title":"Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis","volume":"22","author":"Marchello","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.045_b0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41564-020-00836-1","article-title":"Stepwise evolution of Salmonella Typhimurium ST313 causing bloodstream infection in Africa","volume":"6","author":"Pulford","year":"2020","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.045_b0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jiu045","article-title":"Sequential acquisition of T cells and antibodies to nontyphoidal Salmonella in Malawian children","volume":"210","author":"Nyirenda","year":"2014","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.045_b0115","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1469-0691.2004.00983.x","article-title":"Campylobacter, from obscurity to celebrity","volume":"10","author":"Butzler","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.045_b0120","doi-asserted-by":"crossref","first-page":"17124","DOI":"10.1038\/s41598-019-53533-3","article-title":"Determinants of Campylobacter infection and association with growth and enteric inflammation in children under 2 years of age in low-resource settings","volume":"9","author":"Haque","year":"2019","journal-title":"Sci Rep"},{"issue":"10051","key":"10.1016\/j.vaccine.2023.11.045_b0125","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2023.11.045_b0130","doi-asserted-by":"crossref","first-page":"e1319","DOI":"10.1016\/S2214-109X(18)30351-6","article-title":"Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study","volume":"6","author":"Rogawski","year":"2018","journal-title":"Lancet Global Health"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.045_b0135","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/21645515.2018.1528410","article-title":"Update on Campylobacter vaccine development","volume":"15","author":"Poly","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.045_b0140","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41587-022-01249-7","article-title":"Development of spirulina for the manufacture and oral delivery of protein therapeutics","volume":"40","author":"Jester","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.045_b0145","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1021\/acsinfecdis.0c00831","article-title":"Modeling enteropathy or diarrhea with the top bacterial and protozoal pathogens: differential determinants of outcomes","volume":"7","author":"Guerrant","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.vaccine.2023.11.045_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104257","article-title":"Biomarkers of environmental enteric dysfunction and adverse birth outcomes: an observational study among pregnant women living with HIV in Tanzania","volume":"84","author":"Kirby","year":"2022","journal-title":"EBioMedicine"},{"issue":"Supplement_7","key":"10.1016\/j.vaccine.2023.11.045_b0155","doi-asserted-by":"crossref","first-page":"S848","DOI":"10.1093\/infdis\/jiab434","article-title":"Pathogens associated with linear growth faltering in children with diarrhea and impact of antibiotic treatment: the Global Enteric Multicenter Study","volume":"224","author":"Nasrin","year":"2021","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.045_b0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12916-019-1417-3","article-title":"Environmental enteric dysfunction: a review of potential mechanisms, consequences and management strategies","volume":"17","author":"Tickell","year":"2019","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.045_b0165","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1891852","article-title":"Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge model","volume":"13","author":"Brubaker","year":"2021","journal-title":"Gut Microbes"},{"issue":"9","key":"10.1016\/j.vaccine.2023.11.045_b0170","doi-asserted-by":"crossref","first-page":"e0008711","DOI":"10.1371\/journal.pntd.0008711","article-title":"Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Malian children","volume":"14","author":"Arndt","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.045_b0175","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1128\/IAI.01021-09","article-title":"Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans","volume":"78","author":"Tribble","year":"2010","journal-title":"Infect Immun"},{"issue":"32","key":"10.1016\/j.vaccine.2023.11.045_b0180","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.vaccine.2018.06.063","article-title":"A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei","volume":"36","author":"Frenck","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.045_b0185","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/vaccines10040548","article-title":"From concept to clinical product: a brief history of the novel Shigella Invaplex vaccine\u2019s refinement and evolution","volume":"10","author":"Turbyfill","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.vaccine.2023.11.045_b0190","doi-asserted-by":"crossref","first-page":"e0005039","DOI":"10.1371\/journal.pntd.0005039","article-title":"Biomarkers of environmental enteropathy are positively associated with immune responses to an oral Cholera vaccine in Bangladeshi children","volume":"10","author":"Uddin","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2023.11.045_b0195","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ebiom.2015.09.036","article-title":"Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh","volume":"2","author":"Naylor","year":"2015","journal-title":"eBioMedicine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.045_b0200","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00637-21","article-title":"Enterotoxigenic Escherichia coli enterotoxins regulate epithelial to immune relay of IL-33 and IL-1Ra cytokines","volume":"90","author":"Motyka","year":"2022","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.045_b0205","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/s41598-018-20740-3","article-title":"Activated T follicular helper-like cells are released into blood after oral vaccination and correlate with vaccine specific mucosal B-cell memory","volume":"8","author":"C\u00e1rdeno","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.11.045_b0210","first-page":"12","article-title":"A systems biology approach identifies B cell maturation antigen (BCMA) as a biomarker reflecting oral vaccine induced IgA antibody responses in humans","author":"Mottram","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.045_b0215","doi-asserted-by":"crossref","first-page":"e0007823","DOI":"10.1371\/journal.pntd.0007823","article-title":"A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea \u2013 dose optimization, clinical outcomes, and CD4+ T cell responses","volume":"13","author":"Sakkestad","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.045_b0220","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(20)30488-6","article-title":"Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study","volume":"21","author":"Cohen","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.11.045_bib221","unstructured":"PATH. Shigella vaccines for traveler and military populations: A market assessment report. Published April 2023. Accessed November 27, 2023. https:\/\/www.path.org\/resources\/shigella-vaccines-for-traveler-and-military-populations-a-market-assessment-report\/."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:34:24Z","timestamp":1759404864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23013919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X23013919"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}